Traws Pharma, Inc., Newtown PA: raising $50,000,000 (Healthcare & Life Sciences), filed 2026-11-05
Traws Pharma, Inc. (Newtown, Pennsylvania): raising $50,000,000 (Healthcare & Life Sciences), filed 2026-11-05. Its amount of 50,000,000 is top-decile (99th percentile of 505 records). Dated 2 days ago, it is inside the fresh trigger window. Score 75/100. As of 2026-11-06, from SEC EDGAR Form D via FormDPulse (operating companies only, no individuals).
Data as of · Compiled by Zalwin from SEC EDGAR Form D via FormDPulse (operating companies only, no individuals)
amount: 50,000,000 · 99th percentile of 505 FundedAndHiringPulse records · 9.3x the median
Free preview: all 9 published fields of this record are shown below. Locked: 5 related PA FundedAndHiringPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Company | Traws Pharma, Inc. |
| Location | Newtown, PA |
| Industry | Biotechnology |
| Likely hiring | Healthcare and life sciences (clinical, R&D) |
| Offering | $50,000,000 |
| Sold so far | $0 |
| Filed | 2026-11-05 (2 days ago) |
| Revenue range | Decline to Disclose |
| Next steps | Find the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page. |
| amount percentile | 99th of 505 (median 5,400,000, 9.3x median) |
| Peer records CSV (6 PA records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Traws Pharma, Inc.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Traws Pharma + all 6 PA records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Company · State · Sector · Offering · Filed · official source URL
- Source agency: SEC EDGAR Form D via FormDPulse (operating companies only, no individuals)
- Record date: 2026-11-05
- Data refreshed: 2026-11-06
- Refunds on request within 14 days
Top FundedAndHiringPulse records (PA first): DIMECO INC, Honesdale PA · Zenith GPO Inc, Radnor PA · Septal Solutions, Inc., Exton PA · BioLattice Ophthalmics, Inc,, Philadelphia PA · Telemachus Therapeutics, Inc., Wexford PA · Browse all by state and category →
LIVE PUBLIC DATA Source: SEC EDGAR Form D via FormDPulse (operating companies only, no individuals) · Last refreshed: Fri, 06 Nov 2026 15:46:18 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Traws Pharma, Inc. and 6 Pennsylvania peers
- Pennsylvania FundedAndHiringPulse records like this one: 6
- Traws Pharma, Inc.'s amount: 99th percentile of 505 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every Pennsylvania peer: $1,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
75 / 100 Scaling Signal Score
- Raise of $5M+: budget for several hires.
- Sector with high hiring intensity after a raise.
- Filed in the last two weeks.
What is the FundedAndHiringPulse record for Traws Pharma, Inc. in Newtown, Pennsylvania?
Traws Pharma, Inc. (PA) filed a Form D on 2026-11-05 for a $50,000,000 offering in Biotechnology.
How does Traws Pharma, Inc. compare to other Pennsylvania FundedAndHiringPulse records?
This is a top-decile record: its amount of 50,000,000 is 9.3x the median of 5,400,000 across 505 records. It is fresh: dated 2 days ago, inside the window where early outreach matters most. Its Scaling Signal Score of 75/100 puts it among the stronger signals in this feed.
Traws Pharma, Inc. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date | Compare |
|---|---|---|---|---|---|
| Traws Pharma, Inc. | Newtown, PA | 50,000,000 | 99th | 2026-11-05 | This record |
| DIMECO INC | Honesdale, PA | 25,000,000 | 91st | 2026-11-03 | Compare Traws Pharma, Inc. vs DIMECO INC → |
| Zenith GPO Inc | Radnor, PA | 14,999,900 | 78th | 2026-10-30 | Compare Traws Pharma, Inc. vs Zenith GPO Inc → |
| Septal Solutions, Inc. | Exton, PA | 10,000,000 | 68th | 2026-10-27 | View record → |
Related records
FundedAndHiringPulse: records in Pennsylvania FundedAndHiringPulse: Healthcare and life sciences (clinical, R&D) FundedAndHiringPulse: $25M-$50M
More Pennsylvania public-record feeds
Pennsylvania Sales, Use & Hotel Occupancy Tax Licenses and Certificates Cur in Pennsylvania Excluded Health Care Business Search (OIG LEIE) in Pennsylvania New, Terminating & Large 401(k) Plans from Form 5500 Filings in Pennsylvania HIPAA Breach Reports (500+ Individuals) by State & Type in Pennsylvania School & Library E-Rate Contracts Up for Rebid in Pennsylvania New Health-Based Drinking Water Violations by Water System (EPA SDWIS) in Pennsylvania SEC 8-K Corporate Trigger Events in Pennsylvania Nonprofit Revenue, Expenses & Assets from Form 990 in Pennsylvania
How to monitor Traws Pharma, Inc. and peer healthcare and life sciences (clinical, r&d) records
Get new FundedAndHiringPulse records like Traws Pharma, Inc. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new funded companies in your niche every week
FundedAndHiringPulse can email you new filers matching your states, hiring classes and raise sizes.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Built from SEC Form D filings, which report an offering, not a hiring plan; "likely to hire" is our classification from industry and raise size, not a statement by the company. Filings can be amended or withdrawn; confirm on SEC EDGAR. Companies only; individuals named in filings are not included. Not a consumer report and may not be used for FCRA purposes. Not investment advice.